quinazolines has been researched along with Empyema, Gall Bladder in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, KP; Shih, JY; Yu, CJ | 1 |
Bond, M; Michael, M; Saccone, GT; Sandstrom, P; Svanvik, J; Toouli, J; Woods, CM | 1 |
2 other study(ies) available for quinazolines and Empyema, Gall Bladder
Article | Year |
---|---|
Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Chemotherapy, Adjuvant; Cholecystitis; Cisplatin; Combined Modality Therapy; DNA Mutational Analysis; Female; Gefitinib; Genes, erbB-1; Genetic Predisposition to Disease; Humans; Incidental Findings; Lung Neoplasms; Mutation; Neoplasm Staging; Pedigree; Pneumonectomy; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Vinblastine; Vinorelbine | 2010 |
Selective iNOS inhibition enhances spontaneous gallbladder motility in the Australian possum.
Topics: Animals; Cholecystitis; Enzyme Inhibitors; Female; Gallbladder; Gallbladder Emptying; Gene Expression; Male; Nitric Oxide Synthase Type II; Organ Culture Techniques; Polymerase Chain Reaction; Quinazolines; RNA, Messenger; Trichosurus | 2007 |